Reshape Lifesciences Inc (RSLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Sales | 72 | 149 | 64 | 79 | 0 |
| Cost of Goods | 40 | 71 | 23 | 31 | N/A |
| Gross Profit | 32 | 78 | 41 | 48 | N/A |
| Operating Expenses | 7,614 | 7,700 | 6,074 | 7,420 | 6,964 |
| Operating Income | -7,542 | -7,551 | -6,010 | -7,341 | -6,964 |
| Interest Expense | 1,149 | 99 | 566 | 60 | 215 |
| Other Income | 1,282 | 880 | 2,425 | -3 | 5 |
| Pre-tax Income | -7,409 | -6,770 | -4,151 | -7,404 | -7,174 |
| Net Income Continuous | -7,409 | -6,770 | -4,151 | -7,404 | -7,174 |
| Net Income | $-7,409 | $-6,770 | $-4,151 | $-7,404 | $-7,174 |
| EPS Basic Total Ops | -66.14 | -295.40 | -0.60 | -1.49 | -1.48 |
| EPS Basic Continuous Ops | -66.14 | -295.39 | -0.60 | -1.49 | -1.48 |
| EPS Diluted Total Ops | -66.14 | -295.40 | -0.60 | -1.49 | -1.48 |
| EPS Diluted Continuous Ops | -66.14 | -295.39 | -0.60 | -1.49 | -1.48 |
| EBITDA(a) | $-6,687 | $-7,437 | $-5,404 | $-7,261 | $-6,750 |